90% of pharmaceutical companies count China as a top priority for growth.A survey conducted by Biopharma Reporter today reported that North America and Western Europe are considered the most important pharmaceutical markets today, coming in at 88 percent and 71 percent respectively. China slipped in at third place thanks…
Learn more about the market for aseptic injectables in China and how your company can take advantage of this high-growth opportunity.
With two decades of experience in aseptic fill-and-finish contract manufacturing in China, PaizaBio allows you to enter the market with utmost confidence and quality products.